Back
CVS Health Vs. Nebius Group NV Industry Stock Comparison
Buy
70
CVS
CVS Health
Last Price:
$66.93
Seasonality Move:
4.24%
Sell
41
NBIS
Nebius Group NV
Last Price:
$40.83
Seasonality Move:
-1.2%
Buy
70
CVS Health (CVS)
is a Buy
Is CVS Health a Buy, Sell or Hold?
-
The current CVS Health [CVS] share price is $63.22. The Score for CVS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
CVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $39.30. The Score for NBIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $63.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $39.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.
CVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.81 | Buy |
Relative Strength Index (14 RSI): | 77.7 | Buy |
Chaikin Money Flow: | 18384513 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.24 - 57.48) | Buy |
Bollinger Bands (100): | (49.44 - 61.38) | Buy |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.97 | Buy |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | -4876323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.37 - 39.25) | Buy |
Bollinger Bands (100): | (18.9 - 33.32) | Buy |
CVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.09 | Buy |
20-day SMA: | 55.19 | Buy |
50-day SMA: | 51.67 | Buy |
200-day SMA: | 56.99 | Buy |
8-day EMA: | 56.78 | Buy |
20-day EMA: | 54.88 | Buy |
50-day EMA: | 53.59 | Buy |
200-day EMA: | 58.15 | Buy |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.01 | Buy |
20-day SMA: | 35.73 | Buy |
50-day SMA: | 32.48 | Buy |
200-day SMA: | 22.53 | Buy |
8-day EMA: | 37.71 | Buy |
20-day EMA: | 35.55 | Buy |
50-day EMA: | 32.09 | Buy |
200-day EMA: | 24.66 | Buy |
CVS Health Earnings Growth & CVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.65 per share, and an increase next year of $1.02 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.00 per share.
CVS Health Technical Analysis
Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |